Back to Authors

Sebo, Thomas J.

Mayo Clinic

Northwestern University

Citations 53

MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION
Kipp, Benjamin R. , Karnes, R. Jeffrey , Brankley, Shannon M., Harwood, Aaron R., Sebo, Thomas J., BLUTE, MICHAEL M., Lieber, Michael M., Zincke, Horst, Halling, Kevin C. , Pankratz, V. Shane

Journal of Urology | January 7, 2005 | Volume: 173 | Issue: 2 | Pages: 401-404

10.1097/01.ju.0000149825.83180.a4 Get It

p53 Immunopositivity in Histologically Favorable Wilms Tumor Is Not Related To Stage At Presentation Or To Biological Aggression
D’Angelo, Martina, Kausik, Sankar J., Sebo, Thomas J., Rathbun, Susan, Kramer, S.A., Husmann, Douglas A.

Journal of Urology | August 25, 2004 | Volume: 169 | Issue: 5 | Pages: 1815-1817

10.1097/01.ju.0000061963.54213.84 Get It

Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum
Sebo, Thomas J., Cheville, John C. , Riehle, Darren, Lohse, Christine M. , Myers, Robert P., Blute, Michael L., Zincke, Horst, Pankratz, V. Shane

Cancer | August 25, 2002 | Volume: 91 | Issue: 11 | Pages: 2196-2204

10.1002/1097-0142(20010601)91:11<2196::aid-cncr1249>3.0.co;2-# Get It